Brief: Finch Therapeutics Provides Corporate Update And Reports First Quarter 2022 Financial Results
16/05/2022 13:30
May 16 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
FIRST
QUARTER 2022 FINANCIAL RESULTS
* FINCH THERAPEUTICS GROUP INC - ANTICIPATED CASH RUNWAY
INTO Q2
2024
* FINCH THERAPEUTICS GROUP INC - ENROLLMENT IN PRISM4 PHASE
3
TRIAL OF CP101 IN RECURRENT CDI EXPECTED TO PROCEED IN H2 2022
* FINCH THERAPEUTICS GROUP INC - QTRLY LOSS PER SHARE $0.52
Source text for Eikon: ID:nGNX8ScWrt
Further company coverage: FNCH.O
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp